Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Entrada Therapeutics (TRDA) Q2 2026 Earnings
TRDA
7
May
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.06
-0.85
-0.63
-0.42
Details
Expected EPS
-1.036712
Actual EPS
-0.95
Surprise EPS
0.09
Surprise Percent
+8.36%
Description
Entrada Therapeutics (TRDA) has reported earnings of -0.95 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login